RecruitingNCT07215234
A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
PHASE1 · PHASE2 · 104 planned enrolment
- Countries listed
- 3
- Registry update
- September 22, 2026
